Rmw. Hofstra et al., RET MUTATION SCREENING IN FAMILIAL CUTANEOUS LICHEN AMYLOIDOSIS AND IN SKIN AMYLOIDOSIS ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA, Journal of investigative dermatology, 107(2), 1996, pp. 215-218
In several families, multiple endocrine neoplasia type 2A (MEN 2A) has
been found in association with cutaneous lichen amyloidosis. It has b
een debated, however, whether the skin amyloidosis found in MEN 2A fam
ilies, localized exclusively in the interscapular area, represents the
same anomaly as that found in autosomal dominant familial cutaneous l
ichen amyloidosis, which is more generalized. We screened two MEN 2A f
amilies with associated skin amyloidosis for germline mutations in the
RET gene responsible for the MEN 2A cancer syndrome, and found the sa
me mutation characteristic of MEN 2A in both families, We also screene
d probands from three pedigrees with familial cutaneous lichen amyloid
osis for RET mutations. In none of the RET coding and flanking introni
c sequences was a mutation detected. This most probably indicates that
skin amyloidosis found in some MEN 2A families and familial cutaneous
lichen amyloidosis are different conditions. Consequently, patients w
ith apparent familial cutaneous lichen amyloidosis do not appear to be
at risk for MEN 2A.